期刊文献+

血液透析对患者钙磷代谢影响的临床观察 被引量:1

暂未订购
导出
摘要 目的:通过临床观察探讨常规血液透析与患者代谢之间的关系,怎样控制钙磷代谢紊乱,提高患者的生活,降低患者的死亡率和住院率。方法:选择2009年01月至2010年12月之间在我院透析时间超过6个月的患者68例,晨起空腹采集静脉血,检测血钙、血磷、PTH、血尿素氮、血肌醉和白蛋白这几项指标,每3个月检测一次。残余肾功能(RRF)通过检测尿素和肌配,将68例患者按照RRF和透析龄进行分组考查残余肾功能。结果:RRF值的大小与患者的血钙、PTH浓度没有统计意义,透析龄越高,患者的血磷、PTH浓度有统计意义;血磷、PTH与透析龄均呈正相关;血磷与RRF呈负相关。结论:HD患者的钙磷代谢紊乱随透析龄的延长呈加重趋势。
作者 钟小琴
出处 《中外妇儿健康(学术版)》 2011年第6期258-258,共1页
  • 相关文献

参考文献2

二级参考文献15

  • 1孙鲁英,王梅,杨莉.终末期肾脏病患者钙磷代谢及甲状旁腺激素水平的临床分析[J].北京大学学报(医学版),2005,37(2):147-150. 被引量:64
  • 2陈颢珠.实用内科学[J].第12版,北京:人民卫生出版社,2008:810.
  • 3COODMAN W G, COLDIN J. Coronary artery calcificat - ion in young adults with end stage renal disease who are undergoing dialysis [J]. New Engl Med, 2002, (342): 1478.
  • 4LOPEZ_MENCHERO R, MIGUEL A, GARCIARAMO - NO R,et al. Importance of residual renal function in continued ambulatory peritoneal dialysis:its influence on different paramenters of renal replacement treatment [ J ]. Nephron, 1999,83:219 - 225.
  • 5Braun J, Oldendorf M, Moshage W, et al. Electron beam computed tomography in the evaluation of cardiac calcification in chronic dialysis patients[J]. Am J Kidney Dis,1996,27 : 394 -401.
  • 6Block GA, Hulbert-Shearon TE, Levin NW, et al. Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysls patients :a national study [J]. Am J Kidney Dis, 1998,31 : 607 -617.
  • 7Raggi P, Boulay A, Chasan Taber S, et al. Cardiac calcification in adult hemodialysis patients, a link between end-stage renal disease and cardiovascular disease? [ J ]. J Am Coll Cardiol, 2002,39 (4) : 695 -701.
  • 8Chertow GM, Burke SK, Raggi P. Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients [J]. Kidney Int,2002,62( 1 ) : 245 -252.
  • 9Haese PC, Spasovski GB, Sikole A, et al. A muhicenter study on the effects of lanthanum carbonate( Fosrenol TM)and calcium carbonate on renal bone disease in dialysis patients [J]. Kidney Int, 2003, (Suppl) 85 : 73 - 88.
  • 10Chertow GM, Raggi P, Chasan-Tabar S, et al. Determinants of progressive vascular calcification in hemodialysis patients [J]. Nephrol Dial Transplant ,2004,19 : 1489 - 1496.

共引文献13

同被引文献9

  • 1孙鲁英,王梅,杨莉.终末期肾脏病患者钙磷代谢及甲状旁腺激素水平的临床分析[J].北京大学学报(医学版),2005,37(2):147-150. 被引量:64
  • 2王海燕.肾脏病学[M].北京:人民卫生出版社,2008:1948-1949.
  • 3王质刚.血液净化学[M].第2版.北京:北京科学技术出版社,2005.79,152.
  • 4Kim J, Danese S, Satayathum P, et al. Achievement of proposedNKF-K/DOQI bone metabolism and disease guidelines: resultsfrom the dialysis outcomes and practice patterns study(DOPPS)[J].J Am Soc Nephrol, 2003,14(11): 269-270.
  • 5Eknoyan G, Levin A, Levin NW. Bone metabolism and disease i-n chronic kidney disease [J].Am J Kidney Dis, 2003, 42(2):197-201.
  • 6Cozzolino M,Brancaccio D, Gallieni M, et al. Pathogenesis of va-scular calcification in chronic kidney diseas [J].Kidney Int,2005,68(2):429-436.
  • 7Chertow GM,Raggi P, Chasan-Taber S, et al. Determinants ofprogressive vascular calcification in haemodialysis patients [J].Nephrol Dial Transplant, 2004,19(3): 1489-1496.
  • 8付平,唐万欣.慢性肾脏病患者血管钙化的诊治进展[J].中国血液净化,2008,7(5):233-235. 被引量:20
  • 9许俊福,兰凯,罗群.不同血液净化方法对继发性甲状旁腺功能亢进疗效的观察[J].中国现代医生,2011,49(12):151-152. 被引量:13

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部